Genetic Total Stockholder Equity vs Retained Earnings Analysis

GTG Stock

0.04 0.00 0.00%

Genetic Technologies financial indicator trend analysis is much more than just examining Genetic Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genetic Technologies is a good investment. Please check the relationship between Genetic Technologies Total Stockholder Equity and its Retained Earnings accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.

Total Stockholder Equity vs Retained Earnings

Total Stockholder Equity vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genetic Technologies Total Stockholder Equity account and Retained Earnings. At this time, the significance of the direction appears to have no relationship.

The correlation between Genetic Technologies' Total Stockholder Equity and Retained Earnings is 0.0. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Genetic Technologies, assuming nothing else is changed. The correlation between historical values of Genetic Technologies' Total Stockholder Equity and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Genetic Technologies are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Total Stockholder Equity i.e., Genetic Technologies' Total Stockholder Equity and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most indicators from Genetic Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genetic Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.At this time, Genetic Technologies' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is expected to grow at the current pace this year, whereas Issuance Of Capital Stock is likely to drop slightly above 2.4 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	3.1M	18.1M	3.9M	3.7M
Cost Of Revenue	321.2K	4.3M	3.8M	3.9M

Total Operating Expenses Cost Of Revenue

Genetic Technologies fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Good Will	Other Current Assets	Short Term Debt
Total Assets		0.05	-0.14	0.98	0.81	-0.9	-0.09	-0.2	0.9	0.2	-0.59	0.9	0.09	0.28	-0.16	-0.1	-0.42	-0.08	0.43	0.94	0.32	0.22	-0.4	-0.03	-0.08	-0.35
Other Current Liab	0.05		0.36	-0.06	0.35	0.22	0.08	0.31	-0.19	0.45	-0.11	-0.18	0.24	-0.07	0.16	0.21	-0.14	0.64	0.35	-0.12	-0.02	0.28	0.62	0.09	-0.01	0.07
Total Current Liabilities	-0.14	0.36		-0.31	0.13	0.41	-0.55	0.84	-0.38	0.46	-0.06	-0.38	0.82	0.22	-0.18	-0.19	-0.52	0.73	0.71	-0.31	0.32	0.24	0.22	-0.35	0.1	0.83
Total Stockholder Equity	0.98	-0.06	-0.31		0.73	-0.94	0.0	-0.36	0.93	0.11	-0.55	0.93	-0.06	0.23	-0.1	-0.05	-0.32	-0.26	0.29	0.95	0.26	0.18	-0.49	0.05	-0.09	-0.46
Property Plant And Equipment Net	0.81	0.35	0.13	0.73		-0.55	-0.07	0.12	0.57	0.56	-0.64	0.57	0.29	0.18	-0.1	-0.07	-0.45	0.28	0.62	0.62	0.25	0.38	-0.09	-0.11	-0.11	-0.25
Net Debt	-0.9	0.22	0.41	-0.94	-0.55		0.16	0.47	-1.0	0.21	0.47	-1.0	0.13	-0.4	0.32	0.26	0.24	0.37	-0.15	-0.98	-0.4	0.07	0.49	0.07	0.04	0.47
Retained Earnings	-0.09	0.08	-0.55	0.0	-0.07	0.16		-0.37	-0.18	0.22	0.24	-0.18	-0.5	-0.86	0.75	0.71	0.54	-0.33	-0.59	-0.17	-0.91	0.35	0.08	0.59	-0.38	-0.56
Accounts Payable	-0.2	0.31	0.84	-0.36	0.12	0.47	-0.37		-0.44	0.51	-0.04	-0.44	0.7	0.25	-0.18	-0.18	-0.26	0.83	0.58	-0.39	0.28	0.08	0.26	-0.38	0.01	0.61
Cash	0.9	-0.19	-0.38	0.93	0.57	-1.0	-0.18	-0.44		-0.21	-0.48	1.0	-0.09	0.42	-0.35	-0.28	-0.26	-0.3	0.17	0.99	0.42	-0.08	-0.45	-0.1	-0.04	-0.45
Non Current Assets Total	0.2	0.45	0.46	0.11	0.56	0.21	0.22	0.51	-0.21		-0.39	-0.21	0.3	-0.28	0.29	0.21	-0.19	0.42	0.46	-0.15	-0.2	0.48	0.18	-0.05	-0.12	0.09
Non Currrent Assets Other	-0.59	-0.11	-0.06	-0.55	-0.64	0.47	0.24	-0.04	-0.48	-0.39		-0.48	-0.17	-0.33	0.37	0.43	0.45	-0.15	-0.45	-0.46	-0.39	0.12	-0.11	0.47	0.05	0.19
Cash And Short Term Investments	0.9	-0.18	-0.38	0.93	0.57	-1.0	-0.18	-0.44	1.0	-0.21	-0.48		-0.09	0.42	-0.35	-0.28	-0.26	-0.3	0.17	0.99	0.42	-0.08	-0.44	-0.1	-0.04	-0.45
Net Receivables	0.09	0.24	0.82	-0.06	0.29	0.13	-0.5	0.7	-0.09	0.3	-0.17	-0.09		0.24	-0.18	-0.16	-0.63	0.59	0.67	-0.01	0.32	0.35	0.08	-0.26	-0.35	0.71
Common Stock Total Equity	0.28	-0.07	0.22	0.23	0.18	-0.4	-0.86	0.25	0.42	-0.28	-0.33	0.42	0.24		-0.8	-0.73	-0.36	0.26	0.48	0.38	0.98	-0.53	-0.11	-0.57	0.35	0.2
Common Stock Shares Outstanding	-0.16	0.16	-0.18	-0.1	-0.1	0.32	0.75	-0.18	-0.35	0.29	0.37	-0.35	-0.18	-0.8		0.98	0.06	-0.24	-0.18	-0.26	-0.77	0.75	-0.15	0.88	-0.26	-0.07
Inventory	-0.1	0.21	-0.19	-0.05	-0.07	0.26	0.71	-0.18	-0.28	0.21	0.43	-0.28	-0.16	-0.73	0.98		0.04	-0.19	-0.14	-0.17	-0.7	0.76	-0.2	0.94	-0.21	-0.1
Other Stockholder Equity	-0.42	-0.14	-0.52	-0.32	-0.45	0.24	0.54	-0.26	-0.26	-0.19	0.45	-0.26	-0.63	-0.36	0.06	0.04		-0.31	-0.84	-0.35	-0.49	-0.43	0.17	0.04	-0.07	-0.53
Total Liab	-0.08	0.64	0.73	-0.26	0.28	0.37	-0.33	0.83	-0.3	0.42	-0.15	-0.3	0.59	0.26	-0.24	-0.19	-0.31		0.6	-0.25	0.31	0.05	0.56	-0.38	0.13	0.43
Property Plant And Equipment Gross	0.43	0.35	0.71	0.29	0.62	-0.15	-0.59	0.58	0.17	0.46	-0.45	0.17	0.67	0.48	-0.18	-0.14	-0.84	0.6		0.27	0.61	0.36	-0.1	-0.19	0.21	0.47
Total Current Assets	0.94	-0.12	-0.31	0.95	0.62	-0.98	-0.17	-0.39	0.99	-0.15	-0.46	0.99	-0.01	0.38	-0.26	-0.17	-0.35	-0.25	0.27		0.4	0.06	-0.49	-0.01	-0.04	-0.39
Common Stock	0.32	-0.02	0.32	0.26	0.25	-0.4	-0.91	0.28	0.42	-0.2	-0.39	0.42	0.32	0.98	-0.77	-0.7	-0.49	0.31	0.61	0.4		-0.42	-0.13	-0.55	0.4	0.26
Property Plant Equipment	0.22	0.28	0.24	0.18	0.38	0.07	0.35	0.08	-0.08	0.48	0.12	-0.08	0.35	-0.53	0.75	0.76	-0.43	0.05	0.36	0.06	-0.42		-0.25	0.66	-0.3	0.19
Short Long Term Debt Total	-0.4	0.62	0.22	-0.49	-0.09	0.49	0.08	0.26	-0.45	0.18	-0.11	-0.44	0.08	-0.11	-0.15	-0.2	0.17	0.56	-0.1	-0.49	-0.13	-0.25		-0.38	-0.07	0.1
Good Will	-0.03	0.09	-0.35	0.05	-0.11	0.07	0.59	-0.38	-0.1	-0.05	0.47	-0.1	-0.26	-0.57	0.88	0.94	0.04	-0.38	-0.19	-0.01	-0.55	0.66	-0.38		-0.17	-0.19
Other Current Assets	-0.08	-0.01	0.1	-0.09	-0.11	0.04	-0.38	0.01	-0.04	-0.12	0.05	-0.04	-0.35	0.35	-0.26	-0.21	-0.07	0.13	0.21	-0.04	0.4	-0.3	-0.07	-0.17		0.08
Short Term Debt	-0.35	0.07	0.83	-0.46	-0.25	0.47	-0.56	0.61	-0.45	0.09	0.19	-0.45	0.71	0.2	-0.07	-0.1	-0.53	0.43	0.47	-0.39	0.26	0.19	0.1	-0.19	0.08

Click cells to compare fundamentals

Genetic Technologies Account Relationship Matchups

Genetic Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	15.6M	23.0M	20.8M	14.9M	6.2M	5.9M
Other Current Liab	1.0M	955.5K	1.6M	1.3M	1.1M	940.6K
Total Current Liabilities	1.4M	1.4M	3.8M	3.3M	4.2M	4.4M
Total Stockholder Equity	14.0M	21.5M	16.4M	11.2M	1.8M	1.7M
Property Plant And Equipment Net	440.2K	637.7K	953.3K	599.2K	264.5K	251.3K
Net Debt	(13.7M)	(20.7M)	(11.1M)	(7.3M)	(145.4K)	(152.7K)
Retained Earnings	(136.0M)	(143.1M)	(150.2M)	(156.7M)	(166.4M)	(158.1M)
Accounts Payable	350.2K	269.7K	1.2M	838.0K	1.5M	851.7K
Cash	14.2M	20.9M	11.7M	7.9M	1.0M	969.6K
Non Current Assets Total	440.2K	735.6K	6.1M	4.2M	2.5M	2.4M
Non Currrent Assets Other	(440.2K)	(9.5M)	(6.1M)	(4.2M)	81.7K	85.8K
Cash And Short Term Investments	14.2M	20.9M	11.7M	7.9M	1.0M	969.6K
Net Receivables	38.9K	1.1M	2.4M	191.9K	2.1M	2.2M
Common Stock Shares Outstanding	41.6M	85.4M	92.2M	101.4M	132.2M	263.1M
Liabilities And Stockholders Equity	15.6M	23.0M	20.8M	14.9M	6.2M	5.9M
Inventory	91.4K	76.9K	398.2K	325.9K	206.5K	196.1K
Other Stockholder Equity	1.2M	(10.5M)	(4.9M)	(4.6M)	(4.2M)	(4.0M)
Total Liab	1.6M	1.4M	4.4M	3.7M	4.4M	2.3M
Property Plant And Equipment Gross	440.2K	1.3M	1.9M	1.8M	1.5M	946.1K
Total Current Assets	15.2M	22.2M	14.7M	10.5M	3.7M	3.5M
Common Stock	140.1M	153.6M	155.1M	161.3M	163.8M	99.3M
Property Plant Equipment	440.2K	637.7K	953.3K	599.2K	539.3K	876.6K
Other Current Assets	846.3K	182.6K	18.2K	2.1M	341.7K	390.1K
Short Term Investments	2.0K	1.9K	13.3K	17.4K	18.8K	17.9K
Non Current Liabilities Total	52.3K	33.3K	558.9K	381.6K	160.6K	152.6K
Accumulated Other Comprehensive Income	8.8M	11.0M	11.5M	6.5M	4.4M	4.3M
Other Liab	979.2K	8.9K	170.5K	152.3K	175.2K	133.1K
Net Tangible Assets	13.0M	21.5M	11.3M	7.5M	8.7M	11.1M
Long Term Debt Total	240.9K	24.4K	388.4K	229.3K	263.7K	138.8K
Net Invested Capital	13.1M	21.5M	16.4M	11.2M	2.5M	2.4M
Net Working Capital	13.8M	20.8M	10.9M	7.2M	(500.1K)	(475.1K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC